Literature DB >> 3488728

Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.

J V Haxby, C L Grady, R Duara, N Schlageter, G Berg, S I Rapoport.   

Abstract

Neuropsychological function and resting regional neocortical glucose metabolism, as measured by positron-emission tomography, were studied in 22 patients with mild and moderate Alzheimer's-type dementia. Metabolic reductions in the parietal association cortex and increased left-right metabolic asymmetry were observed in patients with mild and moderate degrees of dementia. Five patients with mild dementia had no impairment of neocortically mediated neuropsychological function, yet they demonstrated these same neocortical metabolic abnormalities. Asymmetry of neocortically mediated, neuropsychological functions correlated with metabolic asymmetries in patients with moderate but not mild dementia. These results suggest that physiological dysfunction in the that physiological dysfunction in the association neocortex is evident in early Alzheimer's-type dementia before the neuropsychological consequences of that dysfunction are demonstrable.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488728     DOI: 10.1001/archneur.1986.00520090022010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  24 in total

1.  Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene.

Authors:  P M Greenwood; T Sunderland; J L Friz; R Parasuraman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 2.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

Review 3.  Mitochondrial dysfunction in neurodegeneration.

Authors:  J M Cooper; A H Schapira
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 4.  An update on the role of mitochondrial α-ketoglutarate dehydrogenase in oxidative stress.

Authors:  Anatoly A Starkov
Journal:  Mol Cell Neurosci       Date:  2012-07-20       Impact factor: 4.314

Review 5.  ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Nadja Smailagic; Marco Vacante; Chris Hyde; Steven Martin; Obioha Ukoumunne; Christos Sachpekidis
Journal:  Cochrane Database Syst Rev       Date:  2015-01-28

6.  Mitochondrial bioenergetics is defective in presymptomatic Tg2576 AD mice.

Authors:  Merina Varghese; Wei Zhao; Jun Wang; Alice Cheng; Xianjuan Qian; Amna Chaudhry; Lap Ho; Giulio Maria Pasinetti
Journal:  Transl Neurosci       Date:  2011-03-01       Impact factor: 1.757

Review 7.  Alzheimer's disease: fundamental and therapeutic aspects.

Authors:  M Schorderet
Journal:  Experientia       Date:  1995-02-15

8.  Primary amnesia of insidious onset with subsequent stabilisation.

Authors:  F Lucchelli; E De Renzi; D Perani; F Fazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

9.  Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type.

Authors:  A Najlerahim; D M Bowen
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 10.  Diagnostic and pharmacological approaches in Alzheimer's disease.

Authors:  C Hermann; R G Stern; M F Losonzcy; S Jaff; M Davidson
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.